v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity attributable to Privia Health Group, Inc.
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2024     120,309,346      
Beginning balance at Dec. 31, 2024 $ 683,447 $ 635,183 $ 1,203 $ 813,209 $ (179,229) $ 48,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     1,081,968      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 2,243 2,243 $ 11 2,232    
Stock-based compensation expense 17,790 17,790   17,790    
Net income 6,046 4,220     4,220 1,826
Ending balance (in shares) at Mar. 31, 2025     121,391,314      
Ending balance at Mar. 31, 2025 $ 709,526 659,436 $ 1,214 833,231 (175,009) 50,090
Beginning balance (in shares) at Dec. 31, 2025 123,604,576   123,604,576      
Beginning balance at Dec. 31, 2025 $ 790,943 737,217 $ 1,236 892,291 (156,310) 53,726
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     2,084,429      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 774 774 $ 21 753    
Stock-based compensation expense 21,921 21,921   21,921    
Repurchase of non-controlling interest (11,444) (9,917)   (9,917)    
Repurchase of non-controlling interest           (1,527)
Net income $ 3,710 3,064     3,064 646
Ending balance (in shares) at Mar. 31, 2026 125,689,005   125,689,005      
Ending balance at Mar. 31, 2026 $ 805,904 $ 753,059 $ 1,257 $ 905,048 $ (153,246) $ 52,845